Credentials & Publications – About Douglas Berger Psychiatrist Tokyo


Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Click here to see a full list of articles.

Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center Director

Douglas Berger, M.D., Ph.D., a fully bilingual American board certified psychiatrist, is the Director of the Tokyo Meguro Counseling Center. Dr. Doug Berger is a graduate of New York Medical College where he completed a 4-year residency program in psychiatry. He then finished a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now based in Tokyo, he had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine.

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

 

Reach out to Douglas Berger psychiatrist Tokyo here.

Has CGT shown "efficacy"? https://t.co/wf3TZAv4tS -not if you think a study needs double-blinding, patient+therapist not just rater blind, and blind placebo as would the FDA to approve a medical treatment of a subjective psychiatric disorder like grief. https://t.co/GwwzyYyjaI

Bui and Shear coauthor “..CLINICAL INTERVIEW FOR COMPLICATED GRIEF…” https://t.co/hbPds7lVil Bui: says though the CG diagnosis is yet to be validated, “The SCI-CG can be used as validated instrument…” Ergo, we can validate an instrument even when diagnosis is not validated?

Bui: Complicated grief treatment (CGT) has “shown efficacy…across 3...trials” authored by Shear https://t.co/wf3TZAv4tS. Bui has worked with Shear, Director of the “Center for Complicated Grief”, which charge fees for workshops up to $600, https://t.co/h6XFgIwROp

Dr. Bui continues, "...studies have found no...differences between bereavement-related depressive syndromes and non-bereavement related depressive syndromes…The bereavement exclusion was dropped in DSM-5 …”: https://t.co/0ao28lbPRt What's going on here?

Dr. Bui: “Persistent Complex Bereavement Disorder PCBD, ” “has been shown to be distinct from mood, anxiety, and other trauma-related disorders despite.. overlap”. But, “…risk factors for PCBD are similar to those for other bereavement-related conditions: https://t.co/0ao28lbPRt

This move will also spur on use of other indications and targets in adults. I may also show add important information to adverse effect profiles. Us: https://t.co/8JFYE38tUu

The chart doesn't speak to the interaction of diseases-i.e., obesity and diabetes, or smoking and drinking w/mortality. Note, psychiatric conditions aren't on the graph, though they have strong correlations with the big killers. Morbidity is a crucial factor leading to morality.

Sudden Onset of Tics, Tantrums, Hyperactivity, and Lability: https://t.co/9GQYRHXzxk Excellent reminder to think of PANDAS when faced with these kinds of children, usually treated with amoxacillin and naproxen, & led by a pediatric neurologist. Us: https://t.co/sooQBqR2nb

Load More...

Narcissists should feel rage when unpraised- Likely, the modest praise gave satisfaction-blush, and inflated praise gave proud feeling. The study's problems: subjects' age, validity of personality tests, unblinded nature of researchers, lack of placebo. https://t.co/59gLBhYuMX

NYT “Tell it about You Mother” suggests psychoanalysis caused brain changes https://t.co/pgQ8YqXBv3. There is 1 fMRI image of 1 patient, no results nor analysis & the 1-patient data is a personal contact from the authors to the NYT. NYT should rewrite. https://t.co/We7OmvxoYF

Sorry to interject economics, science, and politics, in our mental health tweeting. But if this is true then we can still save jobs and our coastlines! Its BIG stuff. Us: https://t.co/2rTavy34n4

There is indeed more acceptance of mental illness AT work, but not more acceptance of seeing a history of mental illness on an application FOR work. All else being equal, management will likely choose the person without problems. How to change this is the question.

The Army Study to Assess Risk and Resilience in Service members found 1/2 of soldiers had some mental disorder at enlistment: https://t.co/R6m6bs75NU It is challenging to mitigate morbidity as many persons enter the military with mental health problems. https://t.co/59gLBhYuMX

Medications previously tested in other indications may help treat CNS disorders: https://t.co/757bnbaLNx Even anti-cancer drugs are being looked at to treat schizophrenia. This is a great "economy of scale" use of clinical trials. Us: https://t.co/4EE55E1tzZ

Brexanolone is a GABAergic drug for post-partum depression that elevates allopreganolone: https://t.co/ALaXT3h6qb Antidepressants still need to be used in patients however & there is no head-to-head comparison of brexanolone vs. antidepressants yet. Us: https://t.co/6oRuH4YcOU

Effects of acupuncture are the same whether placed along the meridians or at random locations: https://t.co/4kGiSkQBsY Acupuncture studies can not be double-blinded, researchers know which patients receive real acupuncture, likely biasing the results. https://t.co/OIlRSavw02

Load More...